Xenetic Biosciences Reports Q3 GAAP EPS of -$0.72 and $0.7 Million in Revenue
Xenetic Biosciences (XBIO) has released its third-quarter financial results, reporting a GAAP earnings per share (EPS) loss of $0.72. The company's revenue for the quarter reached $0.7 million, representing a 30% decline compared to the same period last year. The significant year-over-year decrease in revenue highlights ongoing challenges in the company's top-line growth. Investors will likely monitor these results closely to assess the company's cash burn rate and its ability to navigate current market headwinds.
Tickers: $XBIO
Topics: earnings GAAP EPS revenue decline